When combined with insulin or other medicines that lower blood glucose levels, the patient is at an increased risk of low blood sugar
Serum thiols and ischemia-modified albumin levels in children with major depressive disorder: A cross-sectional study
This challenges the idea that decaf coffee is safer from cancer risks
A single methyl group separates MDMA from MDA, but its a game-changer
Time to Results: Noticeable Appetite Reduction: GLP-1s (semaglutide, tirzepatide): 1-2 weeks Phentermine: 1-3 days Phentermine-topiramate: 1-2 weeks Naltrexone-bupropion: 4-8 weeks Orlistat: Doesnt reduce appetite Measurable Weight Loss: Tirzepatide: 5-8% by week 20, 15-22% by week 72 Semaglutide: 5-7% by week 20, 10-15% by week 68 Phentermine-topiramate: 5-6% by week 28 Others: 3-5% by week 24-28 GLP-1s produce steady, sustained weight loss over 16-20 months
Key survey findings include the following: Medicaid enrollment declined by 7.6% in FY 2025, driven primarily by the unwinding of the continuous enrollment provision